Pre-transplant Dementia is Associated with Poor Survival After Hematopoietic Stem Cell Transplantation: A Nationwide Cohort Study with Propensity Score Matched Control
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Objective: No previous study examined impact of dementia in the outcome of allogeneic hematopoietic stem cell transplantation (HSCT). We aimed to investigate overall survival (OS) of patients with dementia after receiving HSCT. Methods: Among 8,230 patients who underwent HSCT between 2002 and 2018, 5,533 patients younger than 50 years were first excluded. Remaining patients were divided into those who were and were not diagnosed with dementia before HSCT (dementia group: n = 31; no dementia: n = 2,666). Thereafter, among 2,666 participants without dementia, 93 patients were selected via propensity-matched score as non-dementia group. Patients were followed from the day they received HSCT to the occurrence of death or the last follow-up day (December 31, 2018), whichever came first. Results: With median follow-up of 621 days for dementia group and 654 days for non-dementia group, 2 year-OS of dementia group was lower than that of non-dementia group (53.3% [95% confidence interval, 95% CI, 59.0−80.2%] vs. 68.8% [95% CI, 38.0−68.2%], p = 0.076). In multivariate analysis, dementia had significant impacts on OS (hazard risk = 2.539, 95% CI, 1.166−4.771, p = 0.017). Conclusion: Our results indicated that patients diagnosed with dementia before HSCT have 2.539 times higher risk of mortality after transplantation than those not having dementia. With number of elderly needing HSCT is increasing, further work to establish treatment guidelines for the management of HSCT in people with dementia is needed.
Abstract
Objective: No previous study examined impact of dementia in the outcome of allogeneic hematopoietic stem cell transplantation (HSCT). We aimed to investigate overall survival (OS) of patients with dementia after receiving HSCT. Methods: Among 8,230 patients who underwent HSCT between 2002 and 2018, 5,533 patients younger than 50 years were first excluded. Remaining patients were divided into those who were and were not diagnosed with dementia before HSCT (dementia group: n = 31; no dementia: n = 2,666). Thereafter, among 2,666 participants without dementia, 93 patients were selected via propensity-matched score as non-dementia group. Patients were followed from the day they received HSCT to the occurrence of death or the last follow-up day (December 31, 2018), whichever came first. Results: With median follow-up of 621 days for dementia group and 654 days for non-dementia group, 2 year-OS of dementia group was lower than that of non-dementia group (53.3% [95% confidence interval, 95% CI, 59.0−80.2%] vs. 68.8% [95% CI, 38.0−68.2%], p = 0.076). In multivariate analysis, dementia had significant impacts on OS (hazard risk = 2.539, 95% CI, 1.166−4.771, p = 0.017). Conclusion: Our results indicated that patients diagnosed with dementia before HSCT have 2.539 times higher risk of mortality after transplantation than those not having dementia. With number of elderly needing HSCT is increasing, further work to establish treatment guidelines for the management of HSCT in people with dementia is needed.
참고문헌 (47)
- Copelan EA, "Allogeneic hematopoietic cell transplantation; the current renaissance", Blood Rev, 34, pp.34~44 (2019)
- Majhail NS, "Long-term complications after hematopoietic cell transplantation", Hematol Oncol Stem Cell Ther, 10, pp.220~227 (2017)
- Wildes TM, "Hematopoietic stem cell transplantation for hematologic malignancies in older adults : geriatric principles in the transplant clinic", J Natl Compr Canc Netw, 12, pp.128~136 (2014)
- Weir HK, "The past, present, and future of cancer incidence in the United States : 1975 through 2020", Cancer, 121, pp.1827~1837 (2015)
- 정규원, "Prediction of Cancer Incidence and Mortality in Korea, 2016", Cancer Research and Treatment, 48(2), pp.451~457 (2016), 대한암학회
- Hoogland AI, "The role of age in neurocognitive functioning among adult allogeneic hematopoietic cell transplant recipients", Biol Blood Marrow Transplant, 23, pp.1974~1979 (2017)
- Gyurkocza B, "Conditioning regimens for hematopoietic cell transplantation : one size does not fit all", Blood, 124, pp.344~353 (2014)
- Mayo S, "Relationship between neurocognitive functioning and medication management ability over the first 6months following allogeneic stem cell transplantation", Bone Marrow Transplant, 51, pp.841~847 (2016)
- Scherwath A, "Cognitive functioning in allogeneic hematopoietic stem cell transplantation recipients and its medical correlates : a prospective multicenter study", Psychooncology, 22, pp.1509~1516 (2013)
- Phillips KM, "A systematic review and meta-analysis of changes in cognitive functioning in adults undergoing hematopoietic cell transplantation", Bone Marrow Transplant, 48, pp.1350~1357 (2013)
- Ahles TA, "Cancer-and cancer treatment-associated cognitive change : an update on the state of the science", J Clin Oncol, 30, pp.3675~3686 (2012)
- Mandelblatt JS, "Cognitive effects of cancer and its treatments at the intersection of aging: what do we know; what do we need to know?", Semin Oncol, 40, pp.709~725 (2013)
- Rizzo JD, "Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation : joint recommendations of the European Group for Blood and Marrow Transplantation, the Center for International Blood and Marrow Transplant Research, and the American Society of Blood and Marrow Transplantation", Biol Blood Marrow Transplant, 12, pp.138~151 (2006)
- Kelly DL, "Neurocognitive dysfunction in hematopoietic cell transplant recipients : expert review from the late effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and complications and quality of life working party of the European Society for Blood and Marrow Transplantation", Biol Blood Marrow Transplant, 24, pp.228~241 (2018)
- Tarawneh R, "The clinical problem of symptomatic Alzheimer disease and mild cognitive impairment", Cold Spring Harb Perspect Med, 2, pp.a006148~ (2012)
- Hugo J, "Dementia and cognitive impairment : epidemiology, diagnosis, and treatment", Clin Geriatr Med, 30, pp.421~442 (2014)
- Eun-Jeong Min, "Difference in Cognitive Function by First Onset Age of Alcohol Induced Blackout and Its Duration", Clinical Psychopharmacology and Neuroscience, 17(4), pp.503~508 (2019), 대한정신약물학회[DOI]
- Abe S, "Clinical results and issues of acute myeloid leukemia in elderly patients aged 75 years and older", Geriatr Gerontol Int, 11, pp.290~296 (2011)
- Cheng YW, "From mild cognitive impairment to subjective cognitive decline : conceptual and methodological evolution", Neuropsychiatr Dis Treat, 13, pp.491~498 (2017)
- Riyoung Na, "A Systematic Review and Meta-Analysis of Nonpharmacological Interventions for Moderate to Severe Dementia", PSYCHIATRY INVESTIGATION, 16(5), pp.325~335 (2019), 대한신경정신의학회[DOI]
- 송선옥, "Background and Data Configuration Process of a Nationwide Population-Based Study Using the Korean National Health Insurance System", Diabetes and Metabolism Journal, 38(5), pp.395~403 (2014), 대한당뇨병학회[DOI]
- Im GJ, "Prevalence of severe-profound hearing loss in South Korea : a nationwide population-based study to analyse a 10-year trend(2006-2015)", Sci Rep, 8, pp.9940~ (2018)
- Moon I, "Trends of the prevalence and incidence of hypertrophic cardiomyopathy in Korea : a nationwide population-based cohort study", PLoS One, 15, pp.e0227012~ (2020)
- Sorror ML, "Hematopoietic cell transplantation(HCT)-specific comorbidity index : a new tool for risk assessment before allogeneic HCT", Blood, 106, pp.2912~2919 (2005)
- 백승희, "Propensity Score Matching: A Conceptual Review for Radiology Researchers", Korean Journal of Radiology, 16(2), pp.286~296 (2015), 대한영상의학회[DOI]
- Gayat E, "Propensity score applied to survival data analysis through proportional hazards models : a Monte Carlo study", Pharm Stat, 11, pp.222~229 (2012)
- Austin PC, "A critical appraisal of propensity-score matching in the medical literature between 1996 and 2003", Stat Med, 27, pp.2037~2049 (2008)
- Austin PC, "Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies", Pharm Stat, 10, pp.150~161 (2011)
- Parimon T, "A risk score for mortality after allogeneic hematopoietic cell transplantation", Ann Intern Med, 144, pp.407~414 (2006)
- Gerritsen AAJ, "Survival and life-expectancy in a young-onset dementia cohort with six years of follow-up : the NeedYD-study", Int Psychogeriatr, 31, pp.1781~1789 (2019)
- Wolters FJ, "Life expectancy with and without dementia : a population-based study of dementia burden and preventive potential", Am J Epidemiol, 188, pp.372~381 (2019)
- Villarejo A, "Dementia-associated mortality at thirteen years in the NEDICES cohort Study", J Alzheimers Dis, 26, pp.543~551 (2011)
- Hopkinson JB, "People with dementia : what is known about their experience of cancer treatment and cancer treatment outcomes? A systematic review", Psychooncology, 25, pp.1137~1146 (2016)
- McManus RM, "Role of neuroinflammation in neurodegeneration : new insights", Alzheimers Res Ther, 9, pp.14~ (2017)
- Biswa Ranjan Mishra, "Donepezil for Compulsive Behavior in Degenerative Dementia: Case Series", Clinical Psychopharmacology and Neuroscience, 16(2), pp.224~227 (2018), 대한정신약물학회[DOI]
- Won Sang Jung, "Diagnostic Validity of an Automated Probabilistic Tractography in Amnestic Mild Cognitive Impairment", Clinical Psychopharmacology and Neuroscience, 16(2), pp.144~152 (2018), 대한정신약물학회[DOI]
- Artz AS, "Performance status and comorbidity predict transplant-related mortality after allogeneic hematopoietic cell transplantation", Biol Blood Marrow Transplant, 12, pp.954~964 (2006)
- Grauer O, "Neurological manifestations of chronic graft-versus-host disease after allogeneic haematopoietic stem cell transplantation: report from the Consensus Conference on Clinical Practice in chronic graft-versus-host disease", Brain, 133, pp.2852~2865 (2010)
- Heining C, "Lymphocyte reconstitution following allogeneic hematopoietic stem cell transplantation : a retrospective study including 148 patients", Bone Marrow Transplant, 39, pp.613~622 (2007)
- Guerriero F, "Neuroinflammation, immune system and Alzheimer disease : searching for the missing link", Aging Clin Exp Res, 29, pp.821~831 (2017)
- Cao W, "Peripheral immune system in aging and Alzheimer’s disease", Mol Neurodegener, 13, pp.51~ (2018)
- Helmer C, "Mortality with dementia : results from a French prospective community-based cohort", Am J Epidemiol, 154, pp.642~648 (2001)
- Javanshiri K, "Cardiovascular disease, diabetes mellitus, and hypertension in Lewy body disease : a comparison with other dementia disorders", J Alzheimers Dis, 71, pp.851~859 (2019)
- Manabe T, "Prognostic factors related to dementia with Lewy bodies complicated with pneumonia : an autopsy study", Intern Med, 55, pp.2771~2776 (2016)
- Gorin SS, "Treatment for breast cancer in patients with Alzheimer’s disease", J Am Geriatr Soc, 53, pp.1897~1904 (2005)
- Louwman WJ, "Less extensive treatment and inferior prognosis for breast cancer patient with comorbidity : a population-based study", Eur J Cancer, 41, pp.779~785 (2005)
- Velentgas PT, "Developing a protocol for observational comparative effectiveness research : a user’s guide" (2013), Agency for Healthcare Research and Quality